- Home
- GNLX vs LANV Comparison
GNLX vs LANV Comparison
Compare GNLX & LANV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GNLX | LANV |
|---|---|---|
| Founded | 2001 | 2015 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 110.4M | 115.8M |
| IPO Year | 2022 | 2022 |
Fundamental Metrics
Financial Performance| Metric | GNLX | LANV |
|---|---|---|
| Price | $2.11 | $0.79 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $18.83 | N/A |
| AVG Volume (30 Days) | ★ 416.1K | 13.8K |
| Earning Date | 11-09-2026 | 08-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 9.47 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.33 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.86 | $0.76 |
| 52 Week High | $8.54 | $2.31 |
Technical Indicators
Market Signals| Indicator | GNLX | LANV |
|---|---|---|
| Relative Strength Index (RSI) | 40.75 | 33.74 |
| Support Level | N/A | N/A |
| Resistance Level | $2.78 | $1.13 |
| Average True Range (ATR) | 0.21 | 0.06 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 31.91 | 18.10 |
Price Performance
Historical ComparisonAbout GNLX Genelux Corporation
Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.
About LANV Lanvin Group Holdings Limited
Lanvin Group Holdings Ltd engages in offering products ranging from apparel to leather goods, footwear, and accessories. The firm is operating mainly 5 portfolio brands, namely Lanvin, Wolford, Sergio Rossi, St. John, and Caruso. It derives the majority of its revenue from the St. John segment.